Mode of action of two inhibitory peptides from heptad repeat domains of the fusion protein of Newcastle disease virus

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 10, 2002, Pages 1207-1220

  San Roman K ^a   Villar, E ^a   Munoz Barroso I ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

HR synthetic peptides; Membrane fusion; NDV; Paramyxovirus viral fusion

Indexed keywords

HN PROTEIN; HYBRID PROTEIN; SYNTHETIC PEPTIDE; PEPTIDE FRAGMENT; VIRUS PROTEIN;

ARTICLE; ASSAY; BINDING SITE; CELL FUSION; CONTROLLED STUDY; LIPID TRANSPORT; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PHOSPHOLIPID MEMBRANE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN COS1; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; MOLECULAR GENETICS; PATHOGENICITY; VIRULENCE; VIRUS CULTURE;

AMINO ACID SEQUENCE; ANIMAL; COS CELLS; MOLECULAR SEQUENCE DATA; NEWCASTLE DISEASE VIRUS; PEPTIDE FRAGMENTS; PLAQUE ASSAY; REPETITIVE SEQUENCES, AMINO ACID; SUPPORT, NON-U.S. GOV'T; VIRAL PROTEINS; VIRULENCE; ANIMALS;

NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

EID: 0035986610     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00045-6     Document Type: Article

References (51)

1. LearnCoil-VMF: Computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins
2. Buried polar residues in coiled-coil interfaces
3. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
4. Core structure of gp41 from the HIV envelope glycoprotein
5. Atomic structure of the ectodomain from HIV-1 gp41
6. Structural basis for paramyxovirus-mediated membrane fusion
7. Structural characterization of the human respiratory syncytial virus fusion protein core
8. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: Requirements for membrane fusion
9. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia
10. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation
11. Fusogenic activity of reconstituted Newcastle disease virus envelopes: A role for the hemagglutinin-neuraminidase protein in the fusion process
12. Acidic pH enhancement of the fusion of Newcastle disease virus with cultured cells
13. Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus
14. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins
15. Viral and cellular membrane fusion proteins
16. Virus-cell and cell-cell fusion
17. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling
18. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions
19. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein
20. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion
21. HIV-1 inhibition by a peptide
22. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
23. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection
24. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses
25. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion
26. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
27. Membrane-induced step in the activation of Sendai virus fusion protein
28. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion
29. Paramyxovirus F1 protein has two fusion peptides: Implications for the mechanism of membrane fusion
30. Fluorescence method for measuring the kinetics of fusion between biological membranes
31. Evaluation of model discrimination, parameter estimation and goodness of fit in nonlinear regression problems by test statistics distributions
32. Fusion between Newcastle disease virus and erythrocyte ghosts using octadecyl rhodamine B fluorescence assay produces dequenching curves that fit the sum of two exponentials
33. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots
34. Serum-induced leakage of liposome contents
35. Evaluation of viral membrane fusion assays: Comparison of the octadecyl rhodamine dequenching assay with the pyrene excimer assay
36. Probe transfer with and without membrane fusion in a fluorescence fusion assay
37. Use of resonance energy transfer to monitor membrane fusion
38. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41
39. Mode of action of an antiviral peptide from HIV-1: Inhibition at a post-lipid-mixing stage
40. Membrane fusion machines of paramyxoviruses: Capture of intermediate of fusion
41. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events
42. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil
43. The Structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion
44. Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex
45. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion
46. Membrane-induced conformational change during the activation of HIV-1 gp41
47. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41